| Dr Sunni Breann Shepherd Hudson, | |
|
333 Waller Ave Ste 300, Lexington, KY 40504-2927 | |
| (859) 252-3170 | |
| (859) 225-7155 |
| Full Name | Dr Sunni Breann Shepherd Hudson |
|---|---|
| Gender | Female |
| Speciality | Audiologist |
| Location | 333 Waller Ave Ste 300, Lexington, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639491285 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 109995 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sunni Breann Shepherd Hudson, 333 Waller Ave Ste 300, Lexington, KY 40504-2927 Ph: (859) 252-3170 | Dr Sunni Breann Shepherd Hudson, 333 Waller Ave Ste 300, Lexington, KY 40504-2927 Ph: (859) 252-3170 |
News Archive
Post-traumatic stress disorder and alcohol dependence (AD) are two of the most common and debilitating disorders diagnosed among American military veterans. AD and PTSD often occur together, and this co-occurrence has a worse prognosis than either disorder alone.
BNY Mellon, the global leader in asset management and securities servicing, has been appointed by Takeda Pharmaceutical Company Limited (Takeda) as the depositary bank for its sponsored American depositary receipt (ADR) program. Each Takeda ADR represents one-half of a common share and trades on the over-the-counter (OTC) market under the symbol TKPYY. Takeda's common shares trade on the Tokyo Stock Exchange as well as four other exchanges in Japan under the code "4502." Previously, Takeda traded as an unsponsored ADR program serviced by multiple depositaries.
Gemin X Pharmaceuticals, a clinical stage biopharmaceutical company developing novel, targeted cancer therapeutics, today announced the completion of patient enrollment in a Phase 2 clinical trial of the Company's lead product candidate obatoclax (GX15-070) for the treatment of extensive-stage small cell lung cancer (SCLC). The trial is designed to evaluate the efficacy and safety of obatoclax, a novel pan Bcl-2 inhibitor, in combination with standard chemotherapy for the first-line treatment of patients with SCLC.
Giving palliative radiotherapy to elderly patients with painful bone metastases can significantly improve their quality of life, a Dutch researcher told the 2nd Forum of the European Society for Radiotherapy and Oncology (ESTRO) today (Monday).
› Verified 5 days ago
Paula King Evans, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2387 Professional Heights Drive, Suite 30, Lexington, KY 40503 Phone: 859-276-4838 | |
University Of Kentucky Communicative Disorders Audiologist Medicare: Not Enrolled in Medicare Practice Location: 740 S Limestone, Suite B303, Lexington, KY 40536 Phone: 859-257-3390 Fax: 859-323-5951 | |
Sydney Rieman Nance, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1720 Nicholasville Rd Ste 500, Lexington, KY 40503 Phone: 859-278-1114 Fax: 859-277-0541 | |
Shantel J. Dever, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1720 Nicholasville Rd, Suite 500, Lexington, KY 40503 Phone: 859-278-1114 Fax: 859-278-3774 | |
Dr. Courtney Lynn Cooper, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1101 Veterans Dr, Lexington, KY 40502 Phone: 859-281-4972 | |
Abby B. Mattingly, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 740 S Limestone St, Suite B317, Lexington, KY 40536 Phone: 859-257-3390 Fax: 859-323-5951 | |
Trey Anthony Cline, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: University Of Kentucky Department Of, B317 Kentucky Clinic, Lexington, KY 40536 Phone: 859-218-2176 |